Chlamydia Infection Diagnostics and Therapeutics market size was around USD 2.25Posted by miky santhosh on November 26th, 2018 Chlamydia Infection Diagnostics and Therapeutics Market Overview Chlamydia is a sexually transmitted disease. The symptoms do not show early on. It is usually prevailing in the areas with poor sanitation. It is the most common STD worldwide. Number of victims has been increasing over the last decade. Increasing number of cases of these diseases, better reporting in emerging economies, augmenting screening coverage, improved funding for the better R&D in this area, growing awareness regarding STDs in the developing countries along with increased healthcare expenditures, these are the factors driving the growth of this market. Also accessibility and availability of hyper sensitive diagnostic tests are also boosting the growth of this market. Additionally, improved insurance coverage in the emerging economies augurs well for this market. However, the stigma associated with this sexually transmitted diseases is the primary restraint of market growth. Request for Sample @ https://www.marketdataforecast.com/market-reports/chlamydia-infection-diagnostics-and-therapeutics-market-5132/request-sample Like it? Share it! More by this author |